Strides Pharma Science Ltd. (STAR): Strides Pharma Science Share Price Rises 6.59% Today
- September 7, 2026
- Posted by: Harsh Piplani
- Category: News
Strides Pharma Science Share Price is at Rs 1,128.05, up 6.59% today, with market capitalisation at Rs 9,755.1 Cr. The move places Strides Pharma Science Ltd. among the stocks rising today in the Indian stock market, even as the latest Univest data confirms the price event without establishing a company-specific catalyst.
At 07 September 2026 at 11:52:47 AM IST, the stock was trading above the previous close of Rs 1,058.35 after opening at Rs 1,042.05 and touching a high of Rs 1,138.50. The day’s low was Rs 1,042.05, so the price action shows a clear intraday recovery from early levels. For readers tracking Strides Pharma Science Share Price Today, the move is relevant because it combines a higher market cap, a firm share price rise and a turnover of Rs 1.34 Cr, even though the data set does not establish a fresh news trigger. Univest is watching the stock within broader healthcare market updates.
Strides Pharma Science Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,128.05 |
| Previous Close | Rs 1,058.35 |
| Today's Move | Rs 69.7 (+6.59%) |
| Open | Rs 1,042.05 |
| High | Rs 1,138.5 |
| Low | Rs 1,042.05 |
| Turnover | Rs 1.34 crore |
| Market Capitalisation | Rs 9,755.1 crore |
| Market Cap Category | Mid Cap |
Strides Pharma Science Ltd. (STAR) rose to Rs 1,128.05 from the previous close of Rs 1,058.35, a move of Rs 69.7 or 6.59%. The stock opened at Rs 1,042.05, reached a high of Rs 1,138.5, recorded a low of Rs 1,042.05.
Strides Pharma Science Share Price today reflects a strong intraday gain of Rs 69.70, or 6.59%, versus the previous close of Rs 1,058.35. The stock opened below the prior close at Rs 1,042.05, but buyers pushed it to Rs 1,138.50 during the morning trade before it last traded at Rs 1,128.05. That sequence shows the stock moving from an early dip to a stronger price level, which is why Strides Pharma Science Stock News is drawing attention among market movers. The latest Univest figures confirm the price rise, while the latest Univest data does not establish a company-specific catalyst. In simple terms, Strides Pharma Science Share Price Live is being driven by today’s price action rather than a verified event narrative.
Strides Pharma Science Ltd. (STAR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,755.1 crore |
| P/E Ratio | 15.9x |
| P/B Ratio | 2.98x |
| ROE | 20.31% |
| ROCE | 18.57% |
| EPS | Rs 66.56 |
| Book Value Per Share | Rs 355.18 |
| Dividend Yield | 0.47% |
Strides Pharma Science Ltd. (STAR) fundamental metrics show P/E 15.9x, P/B 2.98x, ROE 20.31%, ROCE 18.57%. These figures provide context only and are not a buy or sell signal.
Strides Pharma Science Ltd. has a market capitalisation of Rs 9755.1 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 15.9x, P/B at 2.98x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.31% and ROCE of 18.57%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 66.56, book value per share of Rs 355.18, dividend yield of 0.47%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 15.9x |
| Benchmark Median P/E | 32.83x |
| Benchmark Average P/E | 48.79x |
| Benchmark P/E Range | 3.2x to 659.73x |
| Company P/B Ratio | 2.98x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 20.31% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 18.57% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 9,755.1 crore |
| Benchmark Median Market Cap | Rs 674.09 crore |
Strides Pharma Science Ltd. (STAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Strides Pharma Science Ltd. (STAR) has a P/E ratio of 15.9x, which is below the benchmark median of 32.83x, a difference of -51.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Strides Pharma Science Ltd. (STAR) has a ROE of 20.31%, which is above the benchmark median of 11.78%, a difference of +72.41%. Strides Pharma Science Ltd. (STAR) has a ROCE of 18.57%, which is above the benchmark median of 13.65%, a difference of +36.04%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,633.71 | 37.67 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,576.41 | 82.59 | 13.68 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.58 | 20.55 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.19 | 3.18 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,820.18 | 24.78 | 4.15 | 19.69 | 21.39 |
Strides Pharma Science Ltd. (STAR) has a P/E ratio of 15.9x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.31% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.57% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Strides Pharma Science Ltd. (STAR) has a market capitalisation of Rs 9,755.1 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Strides Pharma Science
- Strides Pharma Science Share Price is up 6.59% today, which keeps it visible among Stocks in News and Top Gainers Today.
- The stock moved from Rs 1,042.05 to Rs 1,138.50 during the day, showing active Price Action in the Share Market Today.
- Valuation remains moderate with a P/E of 15.9 and P/B of 2.98, which supports Strides Pharma Science Fundamental Analysis.
- ROE of 20.31% and ROCE of 18.57% give the stock operating-return context within Healthcare.
- The company’s market cap of Rs 9,755.1 Cr places it above the industry median and keeps Strides Pharma Science Stock News relevant for market watchers.
About Strides Pharma Science
Strides Pharma Science Ltd. operates in Pharmaceuticals & Drugs within the Healthcare sector. The company’s business sits in a part of the Indian stock market where pricing power, regulatory execution and product mix often shape investor attention. While this article focuses on Strides Pharma Science Share Price and today’s market update, the company’s valuation metrics help frame its business quality. The latest Univest data shows a market cap of Rs 9,755.1 Cr, EPS of Rs 66.56, book value of Rs 355.18 and dividend yield of 0.47%. These figures help readers build a grounded view of Strides Pharma Science Company News, especially when compared with sector peers. For those using Univest to study Strides Pharma Science Latest News, the company remains a healthcare name worth tracking for share price update, stock performance and fundamental analysis context.
Frequently Asked Questions
Why is Strides Pharma Science Share Price rising today?
Ans. Strides Pharma Science Share Price is rising 6.59% today, but the latest Univest figures confirm the price event without establishing a company-specific catalyst. The stock is trading at Rs 1,128.05.
What is the current Strides Pharma Science Share Price?
Ans. Strides Pharma Science Share Price is Rs 1,128.05. It is above the previous close of Rs 1,058.35 and has moved within a day range of Rs 1,042.05 to Rs 1,138.50.
How much did Strides Pharma Science stock gain today?
Ans. Strides Pharma Science stock gained Rs 69.70, or 6.59%, today. That move lifted the company’s market capitalisation to Rs 9,755.1 Cr and kept it among the stocks rising today.
What is Strides Pharma Science Market Cap today?
Ans. Strides Pharma Science Market Cap stands at Rs 9,755.1 Cr. Market capitalisation reflects company size in the market, while the share price rise shows how investors are pricing the stock intraday.
What does Strides Pharma Science Fundamental Analysis show?
Ans. Strides Pharma Science Fundamental Analysis shows a P/E of 15.9, P/B of 2.98, ROE of 20.31%, ROCE of 18.57%, EPS of Rs 66.56 and book value of Rs 355.18.
How does Strides Pharma Science compare with healthcare peers?
Ans. Strides Pharma Science trades at a lower P/E than Sun Pharma, Divi's Laboratories and Torrent Pharmaceuticals. Its ROE is also stronger than several peers, while its market cap remains much smaller than the large-cap names.
What sector does Strides Pharma Science belong to?
Ans. Strides Pharma Science belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Its sector context matters because peers in this group often trade on different valuation and return profiles.
Should investors track Strides Pharma Science Share Price on Univest?
Ans. Yes, investors can track Strides Pharma Science Share Price on Univest for live price, valuation ratios, market cap, 52-week markers and broader stock updates in one view. The previous close was Rs 1,058.35.
Track Strides Pharma Science Share Price on Univest
Use Strides Pharma Science Ltd. (STAR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest helps users track Strides Pharma Science Share Price live with market cap, valuation ratios, company financials, sector context and stock updates in one place. Readers can also follow Strides Pharma Science Share Price Today alongside price levels, 52-week markers and broader healthcare market insights. Univest keeps the focus on facts so investors can compare Strides Pharma Science Stock Analysis with the wider Indian stock market without relying on noise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
